Sally Mossman, GSK (EP.65)

Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.

Episode metadata supplied by the publisher feed · Published Sep 21, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Sally Mossman, GSK (EP.65)

0:00 30:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of BioTalk with Rich Bendis?

This episode is 30 minutes long.

When was this BioTalk with Rich Bendis episode published?

This episode was published on September 21, 2020.

Can I download this BioTalk with Rich Bendis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!